Free Trial

Lexeo Therapeutics (LXEO) SEC Filings & 10K Form

Lexeo Therapeutics logo
$2.55 +0.41 (+19.16%)
Closing price 04:00 PM Eastern
Extended Trading
$2.51 -0.04 (-1.61%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Lexeo Therapeutics SEC Filings

DateFilerForm TypeView
04/09/2025
4:44 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
4:46 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
4:48 PM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
5:06 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
6:58 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:17 PM
Lexeo Therapeutics (Filer)
Form S-8 POS
03/24/2025
6:52 AM
Lexeo Therapeutics (Filer)
Form 424B5
03/24/2025
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
6:03 AM
Lexeo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/24/2025
6:04 AM
Lexeo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/21/2025
4:08 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:09 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:09 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:10 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:06 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
11:03 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:55 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM
Lexeo Therapeutics (Subject)
Omega Fund VI, L.P. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
9:24 AM
Lexeo Therapeutics (Subject)
MIZUHO FINANCIAL GROUP INC (Filed by)
Form SCHEDULE 13G
02/12/2025
8:35 AM
Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
01/22/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Rasbach Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:35 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:55 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
1:59 PM
Lexeo Therapeutics (Issuer)
Rasbach Kyle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2024
11:15 PM
Lexeo Therapeutics (Filer)
Form EFFECT
12/19/2024
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
7:19 AM
Lexeo Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/12/2024
4:00 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:18 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
11:15 PM
Lexeo Therapeutics (Filer)
Form EFFECT
11/26/2024
4:00 PM
CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:49 PM
Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
Form SC 13G/A
11/14/2024
11:32 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
11/14/2024
11:23 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
11/13/2024
4:31 PM
Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:33 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:34 PM
Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Altucher: Turn $900 into $108,000 in just 12 months? (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
11/13/2024
6:31 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:32 AM
Lexeo Therapeutics (Filer)
Form 424B3
11/13/2024
6:33 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:35 AM
Lexeo Therapeutics (Filer)
Form 424B3
11/12/2024
8:31 AM
Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G
10/30/2024
5:15 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
5:17 AM
Lexeo Therapeutics (Filer)
Form 424B3
10/15/2024
12:45 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:30 PM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
3:32 PM
Lexeo Therapeutics (Filer)
Form 424B3
09/11/2024
4:17 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:39 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
5:34 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:02 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
6:11 AM
Lexeo Therapeutics (Filer)
Form 424B3
08/09/2024
8:43 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
08/05/2024
11:54 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
07/15/2024
6:55 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
6:59 AM
Lexeo Therapeutics (Filer)
Form 424B3
07/12/2024
3:55 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
5:20 PM
Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
5:26 PM
Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
6:04 AM
Lexeo Therapeutics (Filer)
Form 424B3
06/28/2024
6:33 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
6:36 AM
Lexeo Therapeutics (Filer)
Form 424B3
06/27/2024
4:01 PM
Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:01 PM
CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:02 PM
DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:04 PM
Altschuler Steven (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:05 PM
COOPERSTONE BRENDA (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
8:04 AM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:04 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
4:14 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
6:02 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:07 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:09 AM
Lexeo Therapeutics (Filer)
Form 424B3
04/26/2024
6:55 AM
Lexeo Therapeutics (Filer)
Lexeo Therapeutics (Filer)
Form DEF 14A
04/26/2024
6:56 AM
Lexeo Therapeutics (Filer)
Form DEFA14A
04/26/2024
6:57 AM
Lexeo Therapeutics (Filer)
Form ARS
04/26/2024
6:57 AM
Lexeo Therapeutics (Filer)
Form ARS
04/22/2024
7:22 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
7:23 AM
Lexeo Therapeutics (Filer)
Form 424B3
04/22/2024
7:24 AM
Lexeo Therapeutics (Filer)
Form 424B3
04/22/2024
7:11 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
6:35 AM
Lexeo Therapeutics (Filer)
Form 424B3
04/16/2024
6:32 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:LXEO) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners